Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Brivaracetam SR vs IR Tablets in Healthy Chinese Adults
NCT05622370Phase 1Unknown
- Sponsor
- Overseas Pharmaceuticals
- Start
- Sep 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of brivaracetam in focal-onset epileptic seizures (3 arms), sponsored by Overseas Pharmaceuticals. Primary endpoints: Area under the curve from time zero to the time of the last quantifiable plasma concentration at 1 month, Area under the curve from time zero to infinity at 1 month and 1 more. Status: unknown.
02
Drugs
brivaracetam
03
Conditions
focal-onset epileptic seizures
Beyond the preview
Go deeper on NCT05622370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05622370.